Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (71)

« Back to Publications

Full BLOOD count TRends for colorectal cAnCer deteCtion (BLOODTRACC): external validation of colorectal cancer prediction models in English primary care

Virdee PS. et al, (2025)

Prostate specific antigen retesting intervals and trends in England: population based cohort study

Collins KK. et al, (2025), BMJ Clinical Research Ed, 391

Clinical Prediction Models Incorporating Blood Test Trend for Cancer Detection: Systematic Review, Meta-Analysis, and Critical Appraisal

Virdee PS. et al, (2025), Jmir Cancer, 11

Guideline of guidelines: a critical appraisal of the evidence for PSA retesting intervals

Collins KK. et al, (2025), BJU International

Validity and timeliness of cancer diagnosis data collected during a prospective cohort study and reported by the English and Welsh cancer registries: a retrospective, comparative analysis

Jackson A. et al, (2024), Lancet Oncology, 25, 1476 - 1486

Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trial

Scanlon E. et al, (2024), ESMO Open, 9

etrospective analysis of the validity and timeliness of cancer diagnosis data collected during a prospective cohort study and reported by the English and Welsh cancer registries

Jackson A. et al, (2024), The Lancet Oncology

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial

Mukherjee S. et al, (2024), European Journal of Cancer, 209

Diffusion-weighted magnetic resonance imaging as an early prognostic marker of chemoradiotherapy response in squamous cell carcinoma of the anus: An individual patient data meta-analysis

Hanekamp BA. et al, (2024), Physics and Imaging in Radiation Oncology, 31

The Association between Blood Test Trends and Undiagnosed Cancer: A Systematic Review and Critical Appraisal

Virdee PS. et al, (2024), Cancers, 16

Prioritising primary care patients with unexpected weight loss for cancer investigation: diagnostic accuracy study (update)

Nicholson BD. et al, (2024), BMJ

Standard or High Dose Chemoradiotherapy, with or Without the Protease Inhibitor Nelfinavir, for the Treatment of Locally Advanced Pancreatic Cancer: Efficacy, Safety and Health-Related Quality of Life Outcomes from the Multi-Centre Two Stage Phase 1/Randomised Phase 2 SCALOP-2 Study

Mukherjee S. et al, (2024)

Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study

Nicholson BD. et al, (2023), Lancet Oncology, 24, 733 - 743

Full BLOOD count TRends for colorectal cAnCer deteCtion (BLOODTRACC): development of dynamic prediction models for early detection of colorectal cancer using trends in blood tests from primary care

Virdee PS. et al, (2023)

BLOod Test Trend for cancEr Detection (BLOTTED): protocol for an observational and prediction model development study using English primary care electronic health record data.

Virdee PS. et al, (2023), Diagn Progn Res, 7

Load More

1
2
3
4
5